Official Journals By StatPerson Publication
Table of Content - Volume 11 Issue 1 -July 2019
A study of comparison of duration of intrathecal bupivacaine plus midazolam vs bupivaine alone for postoperatively analgesia in the patients of caesarean delivery
Prashant Mohanrao Patole1, Amruta Vishwanath Dawari2*
1Assistant Professor, Department of Anesthesiology, MIMER Medical College, Talegaon, Dabhade, Pune, INDIA. 2Assistant Professor, Department of Pharmacology, MIMSR Medical College, Latur, Maharashtra, INDIA. Email: gajananchavan2@gmail.com
Abstract Background: Considering the special group of patients (Mothers) undergoing caesarean section, it is moral responsibility of Anaesthesiologist to provide a safe and pain free postoperative period with various drug combinations and techniques. Aims and Objective: A Study duration of intrathecal bupivacaine plus midazolam vs bupivaine alone for postoperatively analgesia in the patients of caesarean delivery Methodology: The present study was carried out during period of January 2009 to September 2009. sixty patients of age group 18-40 years were selected for the presented study .Group A: (n=30) received Inj.Bupivacaine 0.5% heavy 2 ml (10 mg), Group B: (n=30) received Inj. Bupivacaine 0.5% heavy 2 ml (10 mg) + inj. Midazolam 0.5%, 0.2 ml (1mg) . The statistical analysis was done by Chi –square test, unpaired t-test calculated by SPSS 19 version software. Result: In our study we have seen that The mean age in group A and Group B was 23.8 ± 3.47 Yrs. and 24±4 comparable (t=0.207,p>0.05) .The duration of anesthesia was more in Group B i.e. 88.66± 17.75 as compared to 86±16.15 but the difference was not statistically significant (t=0.608,p>0.05) The duration of analgesia was more in Group B i.e. 246±39 as compared to 200 ±21 but the difference was not statistically significant (t=0.608,p>0.05).The doses required for analgesia was less in group A i.e. 2.93±0.630 vs in Group B i.e. 2.96±0.490 but the difference was not statistically significant (t=0.226,p>0.05) Conclusion: Our results not shown any significant differences in both the group hence the combination of use should be compared with side effects and used as per requirement of individual patients Key Word: intrathecal bupivacaine, midazolam, caesarean delivery
INTRODUCTION Considering the special group of patients (Mothers) undergoing caesarean section, it is moral responsibility of Anaesthesiologist to provide a safe and pain free postoperative period with various drug combinations and techniques. The Į2 -adrenergic agonist Clonidine has a variety of different actions including the ability to potentiate the effects of local anesthetics 1. Intrathecal Clonidine is being extensively evaluated as an alternative to neuraxial opioids for control of pain and has proven to be a potent analgesic, free of some of the opioid-related side effects2. Fentanyl, a phenylpiperidine derivative, is a synthetic µ opioid receptor agonist. It is preferred as an adjuvant in spinal anaesthesia because of its rapid onset and short duration of action with lesser incidence of respiratory depression. Intrathecal Fentanyl improves the quality of spinal anaesthesia without having any deleterious effects on the neonate or mother 3. Discovery of benzodiazepine receptors in spinal cord triggered the use of intrathecal Midazolam for analgesia4. Several investigators have shown that intrathecal or epidural administration of Midazolam produces a dose dependent modulation of spinal nociceptive processing in animals and humans and is not associated with neurotoxicity, respiratory depression or sedation 5 So we have done a comparative study of duration of intrathecal bupivacaine plus midazolam vs bupivaine alone for postoperatively analgesia in the patients of caesarean delivery.
METHODOLOGY The present study was carried out during period of January 2009 to September 2009. sixty patients of age group 18-40 years were selected for the presented study. Patients undergoing caesarean section as SA grade I and II and not having fetal distress selected for study. Preoperative evaluation of all patients was done. Through general and systemic examination was done to rule out any systemic disease. All patients undergone all routine testing patients having fetal distress were excluded from the study. Group A: (n=30) received Inj. Bupivacaine 0.5% heavy 2 ml (10 mg) , Group B : (n=30) received Inj. Bupivacaine 0.5% heavy 2 ml (10 mg) + inj. Midazolam 0.5%, 0.2 ml (1mg) . The statistical analysis was done by Chi –square test, unpaired t-test calculated by SPSS 19 version software. RESULT Table 1: Distribution of the patients as per the age
The mean age in group A and Group B was 23. 8 ± 3.47 Yrs. and 24±4 comparable (t=0.207,p>0.05)
Table 2: Distribution of the patients as per the duration of anesthesia
The duration of anesthesia was more in Group B i.e. 88.66± 17.75 as compared to 86±16.15 but the difference was not statistically significant (t=0.608,p>0.05)
Table 3: Distribution of the patients as per the effective analgesia
The duration of analgesia was more in Group B i.e. 246±39 as compared to 200 ±21 but the difference was not statistically significant (t=0.608,p>0.05) Table 4: Distribution of the patients as per the analgesic doses in 24 hours
The doses required for analgesia was less in group A i.e. 2.93±0.630 vs in Group B i.e. 2.96±0.490 but the difference was not statistically significant (t=0.226, p>0.05)
DISCUSSION Spinal subarachnoid block is one of the most versatile regional anesthesia techniques available today. Regional anesthesia offers several advantages over general anesthesia blunts stress response to surgery, decreases intraoperative blood loss, lowers the incidence of postoperative thromboembolic events, and provides analgesia in early postoperative period. Subarachnoid block provides adequate anesthesia for patients undergoing infraumbilical surgery. Among the local anesthetics, 0.5% hyperbaric bupivacaine is the most commonly used drug for spinal anesthesia6. The most important disadvantage of single injection SAB is the limited duration. Adjuvants have long been used along with local anesthetics to prolong the duration of anesthesia and analgesia. Prolongation of pain relief by various adjuvants like opioids like morphine7, fentany8, ketamine9, clonidine10, and neostigmine11 were investigated by various investigators. However, each drug has its limitations and side effects, and the need for an alternative methods and drugs always exist. Discovery of benzodiazepine receptors in spinal cord in 197712 triggered the use of intrathecal midazolam for prolongation of spinal anesthesia. In vitro autoradiography has shown that there is a high density of benzodiazepine (GABAA) receptors in Lamina II of the dorsal horn in the human spinal cord, suggesting a possible role in pain modulation13. So far different animal studies have revealed no damage to the spinal cord, nerve roots, or meninges and in vitro studies suggested that clinically useful doses of intrathecal midazolam are unlikely to be neurotoxic13–17. In our study we have seen that The mean age in group A and Group B was 23.8 ± 3.47 Yrs. and 24±4 comparable (t=0.207,p>0.05)The duration of anesthesia was more in Group B i.e. 88.66± 17.75 as compared to 86±16.15 but the difference was not statistically significant (t=0.608,p>0.05) The duration of analgesia was more in Group B i.e. 246±39 as compared to 200 ±21 but the difference was not statistically significant (t=0.608,p>0.05) The doses required for analgesia was less in group A i.e. 2.93±0.630 vs in Group B i.e. 2.96±0.490 but the difference was not statistically significant (t=0.226,p>0.05) CONCLUSION Our results not shown any significant differences in both the group hence the combination of use should be compared with side effects and used as per requirement of individual patients
REFERENCES
. |
|